Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Lifestyle brand Stanley 1913 uses AI behind the scenes — but execs claim it won’t touch ad creative
Not every brand is racing to let AI anywhere near its ads. Stanley draws the line there on purpose.
TikTok’s Kat Marquez unpacks NBA and WNBA creator deal
TikTok’s latest move to secure its share of the leagues’ growing audiences sees it play gatekeeper between creators and rights holders.
As athletes embrace owned media properties, they’re pushing for more involved brand deals
The NBA player’s union is pushing for stars to have a bigger say in brand deals. It highlights a larger shift in sports and creator marketing.